Transforming Life
Denali Therapeutics is a clinical-stage biotechnology company that invented the TransportVehicle™ platform, enabling biotherapeutics to cross the blood-brain barrier and treat neurodegenerative, lysosomal storage, and other serious diseases. With a clinically validated delivery platform, Denali is advancing a broad pipeline of investigational medicines in collaboration with partners including Biogen and Takeda.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2025
Dec 2025
Mar 2024
Feb 2024
Dec 2017
Aug 2016
May 2015
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...
